UnitedHealth Group stock costs EUR 376.10 below its Xetra close
Published on 10/23/2026 at 11:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and medical cost control
- UnitedHealth raised its 2026 adjusted earnings floor to USD 20.50 per share on October 13, 2026.
- The third-quarter medical care ratio improved to 88.40 percent from 89.90 percent year over year.
- UnitedHealth Group stock trades at EUR 376.10 at 11:14 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.92 percent below the Xetra close of October 22, 2026.
UnitedHealth Group (ISIN US91324P1021) was trading at EUR 376.10 at Lang & Schwarz on October 23, 2026, at 11:14 a.m. CEST, down 0.92 percent versus the Xetra close of October 22, 2026 at EUR 379.60. The latest company figures show a higher earnings floor but continuing pressure from medical costs.
On October 13, 2026, UnitedHealth Group reported third-quarter revenue of USD 112.70 billion and earnings from operations of USD 6.60 billion. Adjusted earnings per share reached USD 4.69, while GAAP earnings per share were USD 4.56.
Medical costs remain the key test
The quarter showed why the stock can hold investor attention even after the earnings release. According to Reuters on October 13, 2026, the consolidated medical care ratio was 88.40 percent, down from 89.90 percent in the year-ago quarter. A lower ratio indicates that a smaller share of premiums was absorbed by medical benefits.
The improvement was not uniform across the business. Reuters reported that UnitedHealthcare revenue fell to USD 86.30 billion from USD 87.10 billion, while group operating income rose to USD 6.60 billion from USD 4.30 billion. That combination puts execution and cost control ahead of headline revenue growth.
What does the higher outlook mean?
UnitedHealth raised its full-year 2026 adjusted earnings outlook to at least USD 20.50 per share, compared with a previous range of USD 19.50 to USD 20.00. CNBC reported on October 13, 2026, that adjusted earnings of USD 4.69 beat the USD 4.14 consensus estimate, while revenue of USD 112.69 billion exceeded the USD 111.40 billion expectation.
The counter-factor is the cost base. CNBC reported that medical costs remained elevated versus historical norms, with inpatient services and specialty pharmacy expenses still under pressure. For investors, the improved ratio must therefore translate into durable margin progress rather than a single-quarter benefit.
Stock stays below the yearly high
At EUR 376.10, the Lang & Schwarz quote stood 6.12 percent below the EUR 400.60 52-week high and above the EUR 222.70 low on October 23, 2026. The finance snapshot also placed UnitedHealth Group's market capitalization at EUR 337.9 billion on that date.
UnitedHealth Group is listed on the NYSE under the ticker UNH. The company combines health insurance, care delivery and pharmacy services, with third-quarter results showing stronger operating earnings alongside lower group revenue.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group stock facts
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 23, 2026, 11:14 a.m. CEST): EUR 376.10
- Change versus Xetra close: minus 0.92 percent
- Xetra close (October 22, 2026): EUR 379.60
- Market capitalization: EUR 337.9 billion (as of October 23, 2026)
- 52-week range: EUR 222.70-400.60 (as of October 23, 2026)
Market context: Market report S&P 500.
